Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt’s lymphoma anti-tumor activityNicola J. Curtis, Susan E. Critchlow|Oncotarget|2017Cited by 155
A functional analysis of 180 cancer cell lines reveals conserved intrinsic metabolic programsSarah Cherkaoui, Nicola Zamboni, Sébastien Dubuis et al.|Molecular Systems Biology|2022Cited by 36
Epithelial-mesenchymal transition is the main driver of intrinsic metabolism in cancer cell linesSarah Cherkaoui, Nicola Zamboni, Stephan Durot et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 2